Works matching IS 00099236 AND DT 2021 AND VI 109 AND IP 1
Results: 34
ASCPT News January.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 17, doi. 10.1002/cpt.2115
- By:
- Publication type:
- Article
Roger W. Jelliffe, MD, FCP, FAAPS: A World Leader in Population Pharmacokinetic and Pharmacodynamic Modeling and Model‐Based Target Controlled Individualized Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 22, doi. 10.1002/cpt.2114
- By:
- Publication type:
- Article
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 212, doi. 10.1002/cpt.2113
- By:
- Publication type:
- Article
Precision Dosing: The Clinical Pharmacology of Goldilocks.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 11, doi. 10.1002/cpt.2112
- By:
- Publication type:
- Article
Physiologically Based Precision Dosing Approach for Drug‐Drug‐Gene Interactions: A Simvastatin Network Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 201, doi. 10.1002/cpt.2111
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 9, doi. 10.1002/cpt.2110
- Publication type:
- Article
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 222, doi. 10.1002/cpt.2102
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 15, doi. 10.1002/cpt.2109
- Publication type:
- Article
Model‐Based Approach to Improve Clinical Outcomes in Neonates With Opioid Withdrawal Syndrome Using Real‐World Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 243, doi. 10.1002/cpt.2093
- By:
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 51, doi. 10.1002/cpt.2092
- By:
- Publication type:
- Article
Continuous Learning in Model‐Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 233, doi. 10.1002/cpt.2088
- By:
- Publication type:
- Article
Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 193, doi. 10.1002/cpt.2087
- By:
- Publication type:
- Article
A Tutorial for Pharmacogenomics Implementation Through End‐to‐End Clinical Decision Support Based on Ten Years of Experience from PREDICT.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 101, doi. 10.1002/cpt.2079
- By:
- Publication type:
- Article
A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response‐Guided Titration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 123, doi. 10.1002/cpt.2068
- By:
- Publication type:
- Article
PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID‐19.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 116, doi. 10.1002/cpt.2067
- By:
- Publication type:
- Article
A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 175, doi. 10.1002/cpt.2065
- By:
- Publication type:
- Article
Precision Dosing: An Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 47, doi. 10.1002/cpt.2064
- By:
- Publication type:
- Article
Supporting Precision Dosing in Drug Labeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 37, doi. 10.1002/cpt.2054
- By:
- Publication type:
- Article
Perspectives on Model‐Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 29, doi. 10.1002/cpt.2049
- By:
- Publication type:
- Article
Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 131, doi. 10.1002/cpt.2033
- By:
- Publication type:
- Article
Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 73, doi. 10.1002/cpt.2028
- By:
- Publication type:
- Article
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 184, doi. 10.1002/cpt.2026
- By:
- Publication type:
- Article
Creatinine‐Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 263, doi. 10.1002/cpt.1991
- By:
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 253, doi. 10.1002/cpt.1990
- By:
- Publication type:
- Article
Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug‐Drug Interaction Risks.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 42, doi. 10.1002/cpt.1984
- By:
- Publication type:
- Article
Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 150, doi. 10.1002/cpt.1972
- By:
- Publication type:
- Article
From Real‐World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods to Address Underlying Challenges.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 87, doi. 10.1002/cpt.1907
- By:
- Publication type:
- Article
Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real‐World Setting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 25, doi. 10.1002/cpt.1933
- By:
- Publication type:
- Article
Drug Dosing Recommendations for All Patients: A Roadmap for Change.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 65, doi. 10.1002/cpt.1923
- By:
- Publication type:
- Article
Interpretation of Cytochrome P‐450 Inhibition and Induction Effects From Clinical Data: Current Standards and Recommendations for Implementation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 82, doi. 10.1002/cpt.1918
- By:
- Publication type:
- Article
Intestinal P‐gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 55, doi. 10.1002/cpt.1916
- By:
- Publication type:
- Article
Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost‐Effectiveness of Preemptive Pharmacogenetic Testing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 160, doi. 10.1002/cpt.1944
- By:
- Publication type:
- Article
The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 140, doi. 10.1002/cpt.1890
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 1, doi. 10.1002/cpt.1895
- Publication type:
- Article